Increased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease
Dysbiosis in the intestinal microbiota of persons with inflammatory bowel disease (IBD) has been described, but there are still varied reports on changes in the abundance of Bifidobacterium and Lactobacillus organisms in patients with IBD. The aim of this investigation was to compare the composition...
Gespeichert in:
| Veröffentlicht in: | Journal of clinical microbiology Jg. 52; H. 2; S. 398 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
United States
01.02.2014
|
| Schlagworte: | |
| ISSN: | 1098-660X, 1098-660X |
| Online-Zugang: | Weitere Angaben |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Dysbiosis in the intestinal microbiota of persons with inflammatory bowel disease (IBD) has been described, but there are still varied reports on changes in the abundance of Bifidobacterium and Lactobacillus organisms in patients with IBD. The aim of this investigation was to compare the compositions of mucosa-associated and fecal bacteria in patients with IBD and in healthy controls (HCs). Fecal and biopsy samples from 21 HCs, 21 and 15 Crohn's disease (CD) patients, and 34 and 29 ulcerative colitis (UC) patients, respectively, were analyzed by quantitative real-time PCR targeting the 16S rRNA gene. The bacterial numbers were transformed into relative percentages for statistical analysis. The proportions of bacteria were uniformly distributed along the colon regardless of the disease state. Bifidobacterium was significantly increased in the biopsy specimens of active UC patients compared to those in the HCs (4.6% versus 2.1%, P = 0.001), and the proportion of Bifidobacterium was significantly higher in the biopsy specimens than in the fecal samples in active CD patients (2.7% versus 2.0%, P = 0.012). The Lactobacillus group was significantly increased in the biopsy specimens of active CD patients compared to those in the HCs (3.4% versus 2.3%, P = 0.036). Compared to the HCs, Faecalibacterium prausnitzii was sharply decreased in both the fecal and biopsy specimens of the active CD patients (0.3% versus 14.0%, P < 0.0001 for fecal samples; 0.8% versus 11.4%, P < 0.0001 for biopsy specimens) and the active UC patients (4.3% versus 14.0%, P = 0.001 for fecal samples; 2.8% versus 11.4%, P < 0.0001 for biopsy specimens). In conclusion, Bifidobacterium and the Lactobacillus group were increased in active IBD patients and should be used more cautiously as probiotics during the active phase of IBD. Butyrate-producing bacteria might be important to gut homeostasis. |
|---|---|
| AbstractList | Dysbiosis in the intestinal microbiota of persons with inflammatory bowel disease (IBD) has been described, but there are still varied reports on changes in the abundance of Bifidobacterium and Lactobacillus organisms in patients with IBD. The aim of this investigation was to compare the compositions of mucosa-associated and fecal bacteria in patients with IBD and in healthy controls (HCs). Fecal and biopsy samples from 21 HCs, 21 and 15 Crohn's disease (CD) patients, and 34 and 29 ulcerative colitis (UC) patients, respectively, were analyzed by quantitative real-time PCR targeting the 16S rRNA gene. The bacterial numbers were transformed into relative percentages for statistical analysis. The proportions of bacteria were uniformly distributed along the colon regardless of the disease state. Bifidobacterium was significantly increased in the biopsy specimens of active UC patients compared to those in the HCs (4.6% versus 2.1%, P = 0.001), and the proportion of Bifidobacterium was significantly higher in the biopsy specimens than in the fecal samples in active CD patients (2.7% versus 2.0%, P = 0.012). The Lactobacillus group was significantly increased in the biopsy specimens of active CD patients compared to those in the HCs (3.4% versus 2.3%, P = 0.036). Compared to the HCs, Faecalibacterium prausnitzii was sharply decreased in both the fecal and biopsy specimens of the active CD patients (0.3% versus 14.0%, P < 0.0001 for fecal samples; 0.8% versus 11.4%, P < 0.0001 for biopsy specimens) and the active UC patients (4.3% versus 14.0%, P = 0.001 for fecal samples; 2.8% versus 11.4%, P < 0.0001 for biopsy specimens). In conclusion, Bifidobacterium and the Lactobacillus group were increased in active IBD patients and should be used more cautiously as probiotics during the active phase of IBD. Butyrate-producing bacteria might be important to gut homeostasis. Dysbiosis in the intestinal microbiota of persons with inflammatory bowel disease (IBD) has been described, but there are still varied reports on changes in the abundance of Bifidobacterium and Lactobacillus organisms in patients with IBD. The aim of this investigation was to compare the compositions of mucosa-associated and fecal bacteria in patients with IBD and in healthy controls (HCs). Fecal and biopsy samples from 21 HCs, 21 and 15 Crohn's disease (CD) patients, and 34 and 29 ulcerative colitis (UC) patients, respectively, were analyzed by quantitative real-time PCR targeting the 16S rRNA gene. The bacterial numbers were transformed into relative percentages for statistical analysis. The proportions of bacteria were uniformly distributed along the colon regardless of the disease state. Bifidobacterium was significantly increased in the biopsy specimens of active UC patients compared to those in the HCs (4.6% versus 2.1%, P = 0.001), and the proportion of Bifidobacterium was significantly higher in the biopsy specimens than in the fecal samples in active CD patients (2.7% versus 2.0%, P = 0.012). The Lactobacillus group was significantly increased in the biopsy specimens of active CD patients compared to those in the HCs (3.4% versus 2.3%, P = 0.036). Compared to the HCs, Faecalibacterium prausnitzii was sharply decreased in both the fecal and biopsy specimens of the active CD patients (0.3% versus 14.0%, P < 0.0001 for fecal samples; 0.8% versus 11.4%, P < 0.0001 for biopsy specimens) and the active UC patients (4.3% versus 14.0%, P = 0.001 for fecal samples; 2.8% versus 11.4%, P < 0.0001 for biopsy specimens). In conclusion, Bifidobacterium and the Lactobacillus group were increased in active IBD patients and should be used more cautiously as probiotics during the active phase of IBD. Butyrate-producing bacteria might be important to gut homeostasis.Dysbiosis in the intestinal microbiota of persons with inflammatory bowel disease (IBD) has been described, but there are still varied reports on changes in the abundance of Bifidobacterium and Lactobacillus organisms in patients with IBD. The aim of this investigation was to compare the compositions of mucosa-associated and fecal bacteria in patients with IBD and in healthy controls (HCs). Fecal and biopsy samples from 21 HCs, 21 and 15 Crohn's disease (CD) patients, and 34 and 29 ulcerative colitis (UC) patients, respectively, were analyzed by quantitative real-time PCR targeting the 16S rRNA gene. The bacterial numbers were transformed into relative percentages for statistical analysis. The proportions of bacteria were uniformly distributed along the colon regardless of the disease state. Bifidobacterium was significantly increased in the biopsy specimens of active UC patients compared to those in the HCs (4.6% versus 2.1%, P = 0.001), and the proportion of Bifidobacterium was significantly higher in the biopsy specimens than in the fecal samples in active CD patients (2.7% versus 2.0%, P = 0.012). The Lactobacillus group was significantly increased in the biopsy specimens of active CD patients compared to those in the HCs (3.4% versus 2.3%, P = 0.036). Compared to the HCs, Faecalibacterium prausnitzii was sharply decreased in both the fecal and biopsy specimens of the active CD patients (0.3% versus 14.0%, P < 0.0001 for fecal samples; 0.8% versus 11.4%, P < 0.0001 for biopsy specimens) and the active UC patients (4.3% versus 14.0%, P = 0.001 for fecal samples; 2.8% versus 11.4%, P < 0.0001 for biopsy specimens). In conclusion, Bifidobacterium and the Lactobacillus group were increased in active IBD patients and should be used more cautiously as probiotics during the active phase of IBD. Butyrate-producing bacteria might be important to gut homeostasis. |
| Author | Zhou, Rui Xia, Bing Wang, Ge Wang, Wei Huang, Sha Wang, Xiaobing Song, Lu Chen, Liping |
| Author_xml | – sequence: 1 givenname: Wei surname: Wang fullname: Wang, Wei organization: Department of Gastroenterology/Hepatology, Zhongnan Hospital of Wuhan University, Wuhan, People's Republic of China – sequence: 2 givenname: Liping surname: Chen fullname: Chen, Liping – sequence: 3 givenname: Rui surname: Zhou fullname: Zhou, Rui – sequence: 4 givenname: Xiaobing surname: Wang fullname: Wang, Xiaobing – sequence: 5 givenname: Lu surname: Song fullname: Song, Lu – sequence: 6 givenname: Sha surname: Huang fullname: Huang, Sha – sequence: 7 givenname: Ge surname: Wang fullname: Wang, Ge – sequence: 8 givenname: Bing surname: Xia fullname: Xia, Bing |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24478468$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkE9LAzEQxYNU1Ko3z5Kjl9Ukm6TJUYt_KhUvCt7K7Ga2RnY3NdlF-hX81G5rBWFghjdvfjxmTEZtaJGQM84uORfm6nH6dMm4Yizj-R454syaTGv2Nvo3H5JxSh-McSmVOiCHQsqJkdocke9ZW0aEhI6uYliF2PnQJhoqeuMr70IBZYfR9w2F1tHuHel8UDayr-s-0WUM_Wq7q0Pa3hV9t47QYTbwXF_6dkl3EKC-HaqqoWmgC3FNi_CFNXU-bRKckP0K6oSnu35MXu9uX6YP2fz5fja9nmelYqbLUEmtKqY4AmqFFQhuQVe8EExXEsHmOS-sMJPcMQ5CgFHgnDXOTLTVRS6OycUvdwj42WPqFo1PJdY1tBj6tODS5hMrjbWD9Xxn7YsG3WIVfQNxvfj7n_gBdv12lw |
| CitedBy_id | crossref_primary_10_1007_s00253_018_9465_8 crossref_primary_10_3390_biology12010057 crossref_primary_10_1093_stmcls_sxac014 crossref_primary_10_1136_gutjnl_2018_316250 crossref_primary_10_1016_j_scitotenv_2022_153455 crossref_primary_10_1186_s40168_020_00940_8 crossref_primary_10_3389_fimmu_2023_1185517 crossref_primary_10_1080_19490976_2021_1990827 crossref_primary_10_1093_ibd_izx029 crossref_primary_10_3390_biomedicines13030708 crossref_primary_10_1016_j_bbi_2024_12_027 crossref_primary_10_3390_ani12233435 crossref_primary_10_3389_fcimb_2025_1516010 crossref_primary_10_1016_j_cgh_2020_03_044 crossref_primary_10_1097_QCO_0000000000000300 crossref_primary_10_3390_microorganisms4020020 crossref_primary_10_1016_j_cyto_2014_11_027 crossref_primary_10_1146_annurev_immunol_032414_112151 crossref_primary_10_1002_ame2_12255 crossref_primary_10_3389_fmicb_2017_01703 crossref_primary_10_3390_cells8020193 crossref_primary_10_1016_j_jff_2023_105690 crossref_primary_10_3390_ijms22179170 crossref_primary_10_1038_s41598_017_14889_6 crossref_primary_10_1016_j_copbio_2017_08_004 crossref_primary_10_3390_ijms231911700 crossref_primary_10_1016_j_jaut_2019_01_001 crossref_primary_10_1093_ecco_jcc_jjaa152 crossref_primary_10_1002_cnr2_1863 crossref_primary_10_3390_nu11112605 crossref_primary_10_3390_medicina59091629 crossref_primary_10_1371_journal_pone_0170034 crossref_primary_10_3389_fcell_2025_1514636 crossref_primary_10_1016_j_bbrc_2018_01_116 crossref_primary_10_1016_j_dld_2018_11_021 crossref_primary_10_1007_s11894_015_0439_z crossref_primary_10_1128_spectrum_00616_22 crossref_primary_10_1097_MIB_0000000000000215 crossref_primary_10_1093_ismejo_wrae226 crossref_primary_10_3390_microorganisms12091864 crossref_primary_10_3390_microorganisms7100440 crossref_primary_10_1016_j_ecoenv_2025_118910 crossref_primary_10_1111_jpn_13703 crossref_primary_10_3389_fcimb_2021_739707 crossref_primary_10_1186_s13099_024_00654_4 crossref_primary_10_3390_ijms252010879 crossref_primary_10_1186_s12917_022_03510_2 crossref_primary_10_3389_fcimb_2019_00112 crossref_primary_10_3389_fphar_2022_972351 crossref_primary_10_1186_s13075_014_0486_0 crossref_primary_10_1159_000495115 crossref_primary_10_1016_j_celrep_2025_115553 crossref_primary_10_3748_wjg_v23_i25_4624 crossref_primary_10_1111_ene_15607 crossref_primary_10_1016_j_carbpol_2019_115460 crossref_primary_10_1097_MCG_0000000000001170 crossref_primary_10_3389_fmicb_2022_856165 crossref_primary_10_1016_j_rmed_2025_108077 crossref_primary_10_1111_adb_12869 crossref_primary_10_1155_2014_872725 crossref_primary_10_1128_msystems_00602_24 crossref_primary_10_3389_fphys_2021_662739 crossref_primary_10_1096_fj_202100920RR crossref_primary_10_1016_j_biopha_2025_118513 crossref_primary_10_1016_j_dld_2015_09_005 crossref_primary_10_1177_2050640619876787 crossref_primary_10_3389_fnut_2021_818902 crossref_primary_10_1186_s12876_020_01444_3 crossref_primary_10_1093_gastro_goae074 crossref_primary_10_1186_s12906_021_03337_8 crossref_primary_10_3390_nu15061338 crossref_primary_10_1126_sciimmunol_adm6843 crossref_primary_10_1016_j_transproceed_2015_12_040 crossref_primary_10_1155_2023_7333511 crossref_primary_10_3390_gastroent12020018 crossref_primary_10_1016_j_chom_2024_08_010 crossref_primary_10_4049_jimmunol_1601621 crossref_primary_10_1038_ncomms12015 crossref_primary_10_1002_eji_202249866 crossref_primary_10_3748_wjg_v25_i36_5543 crossref_primary_10_1002_cpt_2952 crossref_primary_10_1053_j_gastro_2020_11_050 crossref_primary_10_1111_jgh_16043 crossref_primary_10_3390_biomedicines11102658 crossref_primary_10_1186_s12876_019_0930_3 crossref_primary_10_3390_nu13082661 crossref_primary_10_1186_s13073_017_0428_y crossref_primary_10_3389_fimmu_2019_00277 crossref_primary_10_1177_17562848241258360 crossref_primary_10_1177_1352458516682105 crossref_primary_10_2147_JIR_S449335 crossref_primary_10_3390_molecules29020379 crossref_primary_10_1097_MIB_0000000000000307 crossref_primary_10_1038_s41598_018_37143_z crossref_primary_10_1080_19490976_2024_2341457 crossref_primary_10_1016_j_tifs_2022_09_012 crossref_primary_10_3390_immuno2040042 crossref_primary_10_1093_ecco_jcc_jjaa227 crossref_primary_10_1128_AEM_02766_16 crossref_primary_10_1186_s40168_018_0520_6 crossref_primary_10_3390_jcm8091291 crossref_primary_10_1093_ibd_izaa188 crossref_primary_10_3390_nu12051284 crossref_primary_10_1016_j_jep_2022_115145 crossref_primary_10_4103_sjg_sjg_368_22 crossref_primary_10_1016_S1875_5364_24_60600_X crossref_primary_10_3390_pathogens10020152 crossref_primary_10_1017_S0954422415000037 crossref_primary_10_1038_srep35216 crossref_primary_10_3389_fimmu_2020_603594 crossref_primary_10_1089_jmf_2017_0138 crossref_primary_10_1186_s13020_022_00633_4 crossref_primary_10_1186_s12864_018_5306_5 crossref_primary_10_1080_1744666X_2021_1850269 crossref_primary_10_1016_j_jff_2023_105411 crossref_primary_10_1371_journal_pone_0184394 crossref_primary_10_1016_j_jare_2025_05_015 crossref_primary_10_1093_ibd_izac156 crossref_primary_10_3390_jcm9061748 crossref_primary_10_3389_fendo_2023_1220044 crossref_primary_10_1111_exd_14420 crossref_primary_10_3389_fcimb_2022_837019 crossref_primary_10_1038_srep39399 crossref_primary_10_3389_fimmu_2021_658354 crossref_primary_10_1186_s12918_018_0667_6 crossref_primary_10_20935_AcadMolBioGen7642 crossref_primary_10_1093_jn_nxab250 crossref_primary_10_1016_j_micres_2022_127019 crossref_primary_10_1016_j_micpath_2025_108059 crossref_primary_10_1109_TCBB_2018_2831212 crossref_primary_10_3390_ijms24097998 crossref_primary_10_1016_j_suronc_2019_11_005 crossref_primary_10_1111_apt_16096 crossref_primary_10_1038_srep26087 crossref_primary_10_1038_s41420_023_01666_w crossref_primary_10_1128_mSystems_00507_21 crossref_primary_10_1016_j_anaerobe_2022_102652 crossref_primary_10_3390_biom10050766 crossref_primary_10_3390_nu16070989 crossref_primary_10_1007_s13668_023_00475_y crossref_primary_10_1097_JCMA_0000000000000532 crossref_primary_10_1186_s40168_023_01483_4 crossref_primary_10_31146_1682_8658_ecg_220_12_164_182 crossref_primary_10_1038_mi_2014_122 crossref_primary_10_3390_ijms25052753 crossref_primary_10_1093_ibd_izz011 crossref_primary_10_1093_ecco_jcc_jjz077 crossref_primary_10_3389_fmicb_2022_1081591 crossref_primary_10_1186_s12866_024_03368_4 crossref_primary_10_1016_j_foodres_2022_111390 crossref_primary_10_1080_00365521_2016_1216587 crossref_primary_10_3389_fmicb_2019_02101 crossref_primary_10_1038_s41598_022_17296_8 crossref_primary_10_3390_metabo13070873 crossref_primary_10_3390_cells11060944 crossref_primary_10_1111_jch_14598 crossref_primary_10_1016_j_cpr_2020_101943 crossref_primary_10_1017_S0033291722000897 crossref_primary_10_3389_fcimb_2023_1127041 crossref_primary_10_1111_odi_12676 crossref_primary_10_1016_j_micres_2023_127470 crossref_primary_10_1093_ecco_jcc_jjz049 crossref_primary_10_1097_MOG_0000000000000285 crossref_primary_10_3390_ijerph17197081 crossref_primary_10_1038_s41419_021_03395_3 crossref_primary_10_3390_cancers14184403 crossref_primary_10_1186_s12866_023_02999_3 crossref_primary_10_1016_j_micpath_2020_104707 crossref_primary_10_3390_nu14245270 crossref_primary_10_1097_MPG_0000000000000950 crossref_primary_10_1080_13543784_2018_1483333 crossref_primary_10_1016_j_jaut_2023_103062 crossref_primary_10_3390_pathogens8030126 crossref_primary_10_1016_j_ijpharm_2018_01_010 crossref_primary_10_1007_s00253_021_11646_8 crossref_primary_10_1016_j_jff_2024_106414 crossref_primary_10_1016_j_foodres_2022_112010 crossref_primary_10_1038_s41522_020_0119_0 crossref_primary_10_1038_s41551_022_00972_5 crossref_primary_10_1016_j_biopha_2020_109914 crossref_primary_10_7717_peerj_13205 crossref_primary_10_1128_cmr_00210_24 crossref_primary_10_14309_ajg_0000000000000305 crossref_primary_10_1016_j_advms_2020_06_003 crossref_primary_10_1007_s00248_018_1176_2 crossref_primary_10_1038_s41598_020_62811_4 crossref_primary_10_1016_j_biopha_2024_117302 crossref_primary_10_1097_MD_0000000000041262 crossref_primary_10_1097_MIB_0000000000000970 crossref_primary_10_3389_fmed_2022_1000563 crossref_primary_10_5487_TR_2014_30_1_027 crossref_primary_10_3389_fimmu_2024_1399842 crossref_primary_10_3389_fmicb_2022_999001 crossref_primary_10_1007_s10620_020_06133_5 crossref_primary_10_1080_00365521_2023_2223708 crossref_primary_10_1073_pnas_2218739120 crossref_primary_10_3390_microorganisms10112190 crossref_primary_10_3390_ijms26178196 crossref_primary_10_1053_j_gastro_2014_03_001 crossref_primary_10_3389_fmicb_2024_1492783 crossref_primary_10_1007_s13311_017_0574_3 crossref_primary_10_1007_s10096_017_2955_2 crossref_primary_10_1093_femsle_fnab149 crossref_primary_10_1007_s11481_021_10022_7 crossref_primary_10_3389_fmicb_2017_01896 crossref_primary_10_1186_s12906_019_2750_y crossref_primary_10_1007_s12026_025_09655_0 crossref_primary_10_1016_j_bbrc_2025_151584 crossref_primary_10_1038_s41522_025_00714_w crossref_primary_10_1016_j_biopha_2023_114763 crossref_primary_10_3389_fphar_2024_1428242 crossref_primary_10_3390_nu14010004 crossref_primary_10_1111_1758_2229_12411 crossref_primary_10_3389_fmed_2021_716816 crossref_primary_10_3389_fimmu_2016_00290 crossref_primary_10_3390_microorganisms10051044 crossref_primary_10_1053_j_gastro_2019_11_294 crossref_primary_10_1097_MIB_0000000000000641 crossref_primary_10_1016_j_jaci_2018_06_024 crossref_primary_10_3390_ijms25084258 crossref_primary_10_1016_j_molimm_2020_03_008 crossref_primary_10_1177_0963689719873890 crossref_primary_10_1016_j_mam_2025_101349 crossref_primary_10_1177_0023677218818605 crossref_primary_10_1177_2050640619867555 crossref_primary_10_1080_08923973_2018_1469144 crossref_primary_10_1111_asj_13584 crossref_primary_10_1016_j_jiac_2015_07_010 crossref_primary_10_3390_vaccines9060584 crossref_primary_10_1097_MD_0000000000000051 crossref_primary_10_1017_gmb_2022_3 crossref_primary_10_1159_000505036 crossref_primary_10_3389_fmicb_2023_1273269 crossref_primary_10_3390_ijms241713338 crossref_primary_10_1136_egastro_2023_100055 crossref_primary_10_1016_j_carbpol_2025_124097 crossref_primary_10_1017_gmb_2022_5 crossref_primary_10_3390_cells9102283 crossref_primary_10_1093_ibd_izy085 crossref_primary_10_1016_j_anifeedsci_2022_115372 crossref_primary_10_1016_j_sjbs_2018_11_008 crossref_primary_10_1111_ene_13026 crossref_primary_10_1186_s13063_020_04523_8 crossref_primary_10_3390_microorganisms11112750 crossref_primary_10_3390_nu16020247 crossref_primary_10_1007_s00248_019_01462_z crossref_primary_10_1186_s40104_024_00995_9 crossref_primary_10_1038_s41598_024_54257_9 crossref_primary_10_3389_fnut_2023_1130841 crossref_primary_10_3390_ijms26062503 crossref_primary_10_1134_S1990750816020037 crossref_primary_10_1039_D2FO01165D crossref_primary_10_32604_biocell_2023_025311 crossref_primary_10_1007_s42485_021_00062_1 crossref_primary_10_3389_fimmu_2023_1004756 crossref_primary_10_3390_ijms26072939 crossref_primary_10_1111_1469_0691_12799 crossref_primary_10_1038_s41467_025_56829_3 crossref_primary_10_1016_j_biopha_2025_118268 crossref_primary_10_3390_microorganisms4030034 crossref_primary_10_1016_j_isci_2024_110853 crossref_primary_10_3390_ijms23158494 crossref_primary_10_1371_journal_pone_0300678 crossref_primary_10_1016_j_anaerobe_2017_02_010 crossref_primary_10_1097_MCG_0000000000000772 crossref_primary_10_1371_journal_pone_0276910 crossref_primary_10_3390_fermentation9090827 crossref_primary_10_1093_ecco_jcc_jjac001 crossref_primary_10_3389_fvets_2024_1456181 crossref_primary_10_1038_pr_2015_115 crossref_primary_10_1371_journal_pone_0277576 crossref_primary_10_3390_ijms20020283 crossref_primary_10_1002_mnfr_201800160 crossref_primary_10_3389_fmed_2022_1023896 crossref_primary_10_3390_microorganisms12112333 crossref_primary_10_1128_CMR_00060_18 crossref_primary_10_3390_nu13093157 crossref_primary_10_1038_s41467_022_34667_x crossref_primary_10_1186_s13293_024_00590_7 crossref_primary_10_3390_nu12051423 crossref_primary_10_3748_wjg_v27_i23_3317 crossref_primary_10_3390_ijms22063076 crossref_primary_10_1097_MIB_0000000000000029 crossref_primary_10_1002_jsfa_12254 crossref_primary_10_1016_j_bcp_2018_07_044 crossref_primary_10_1007_s10620_016_4229_8 crossref_primary_10_3389_fimmu_2021_674313 crossref_primary_10_3390_cancers15061913 crossref_primary_10_1038_s41531_025_00894_4 crossref_primary_10_1186_s40168_016_0176_z crossref_primary_10_3390_nu14020260 crossref_primary_10_1039_D3FO05337G crossref_primary_10_3390_nu10081055 crossref_primary_10_1080_19490976_2021_1907270 crossref_primary_10_3748_wjg_v20_i40_14805 crossref_primary_10_1016_j_heliyon_2021_e06432 crossref_primary_10_1038_s41591_018_0308_z crossref_primary_10_3390_microorganisms10010073 crossref_primary_10_3390_ijms22063061 crossref_primary_10_13105_wjma_v8_i2_54 crossref_primary_10_1136_bmjopen_2018_021987 crossref_primary_10_1002_jsfa_12382 crossref_primary_10_1111_jgh_15222 crossref_primary_10_3390_microorganisms9050977 crossref_primary_10_1186_s12915_023_01748_2 crossref_primary_10_3390_nu12123749 crossref_primary_10_3390_nu16060773 crossref_primary_10_1371_journal_pone_0116465 crossref_primary_10_3390_ijms241914925 crossref_primary_10_3390_ph17040490 crossref_primary_10_1038_s41598_019_49829_z crossref_primary_10_1128_spectrum_00823_24 crossref_primary_10_3389_fonc_2022_813745 crossref_primary_10_3389_fimmu_2018_03183 crossref_primary_10_1002_mdc3_12840 crossref_primary_10_3389_fcimb_2017_00051 crossref_primary_10_2147_DMSO_S291822 crossref_primary_10_1016_j_prmcm_2025_100655 crossref_primary_10_3390_ijms26073148 crossref_primary_10_1007_s10753_023_01870_x crossref_primary_10_1093_femsre_fuaa015 crossref_primary_10_3389_fmicb_2023_1202768 crossref_primary_10_3389_fnut_2021_778542 crossref_primary_10_3390_ani12010123 crossref_primary_10_3390_nu11112629 crossref_primary_10_1007_s00108_013_3443_0 crossref_primary_10_3389_fmicb_2019_00322 crossref_primary_10_1007_s00281_014_0454_4 crossref_primary_10_3748_wjg_v20_i28_9468 crossref_primary_10_1212_NXI_0000000000000907 crossref_primary_10_1093_ecco_jcc_jjad204 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1128/JCM.01500-13 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine Biology |
| EISSN | 1098-660X |
| ExternalDocumentID | 24478468 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- .55 .GJ 0R~ 18M 29K 2WC 39C 3O- 4.4 41~ 53G 5GY 5RE 5VS AAGFI ABOCM ABPPZ ACGFO ADBBV AENEX AGCDD AGVNZ AI. ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW CGR CS3 CUY CVF D-I DIK DU5 E3Z EBS ECM EIF EJD F5P FRP GX1 H13 HF~ HYE HZ~ H~9 KQ8 L7B NPM O9- OHT OK1 P2P P6G RHI RNS RPM RSF TR2 VH1 W8F WHG WOQ X7M ZCA ZGI ZXP ~KM 7X8 |
| ID | FETCH-LOGICAL-c508t-e5465f051eae65efa219a6f1b206f4ea9331b92873d01a22a85add98d87696b32 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 392 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000330444200005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1098-660X |
| IngestDate | Thu Sep 04 17:36:23 EDT 2025 Mon Jul 21 06:05:33 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c508t-e5465f051eae65efa219a6f1b206f4ea9331b92873d01a22a85add98d87696b32 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://jcm.asm.org/content/jcm/52/2/398.full.pdf |
| PMID | 24478468 |
| PQID | 1493794899 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_1493794899 pubmed_primary_24478468 |
| PublicationCentury | 2000 |
| PublicationDate | 2014-Feb 20140201 |
| PublicationDateYYYYMMDD | 2014-02-01 |
| PublicationDate_xml | – month: 02 year: 2014 text: 2014-Feb |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Journal of clinical microbiology |
| PublicationTitleAlternate | J Clin Microbiol |
| PublicationYear | 2014 |
| References | 22520466 - Cell Host Microbe. 2012 Apr 19;11(4):387-96 14517348 - Mol Cancer Res. 2003 Sep;1(11):855-62 19756155 - PLoS One. 2009;4(9):e7056 21530738 - Gastroenterology. 2011 May;140(6):1720-28 12089021 - Appl Environ Microbiol. 2002 Jul;68(7):3401-7 17119388 - Inflamm Bowel Dis. 2006 Dec;12(12):1136-45 19197385 - PLoS One. 2009;4(2):e4365 17890331 - Appl Environ Microbiol. 2007 Nov;73(22):7435-42 17699621 - Proc Natl Acad Sci U S A. 2007 Aug 21;104(34):13780-5 18242222 - Gastroenterology. 2008 Feb;134(2):577-94 11375166 - Appl Environ Microbiol. 2001 Jun;67(6):2578-85 18936492 - Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16731-6 3569765 - Gastroenterology. 1987 Jun;92(6):1894-8 15867587 - Inflamm Bowel Dis. 2005 May;11(5):473-80 19343057 - Nat Rev Immunol. 2009 May;9(5):313-23 15479682 - Gut. 2004 Nov;53(11):1617-23 21219646 - BMC Microbiol. 2011;11:7 18590586 - Br J Nutr. 2009 Feb;101(4):541-50 21282652 - Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4623-30 16000463 - J Clin Microbiol. 2005 Jul;43(7):3380-9 19174792 - Am J Gastroenterol. 2009 Feb;104(2):437-43 22693446 - PLoS Pathog. 2012;8(5):e1002714 15867588 - Inflamm Bowel Dis. 2005 May;11(5):481-7 19026645 - Gastroenterology. 2009 Jan;136(1):65-80 20816835 - Gastroenterology. 2010 Dec;139(6):1844-1854.e1 19714743 - Inflamm Bowel Dis. 2010 Mar;16(3):390-400 12374228 - Scand J Gastroenterol. 2002 Sep;37(9):1034-41 22132181 - PLoS One. 2011;6(11):e27961 1248701 - Gastroenterology. 1976 Mar;70(3):439-44 12524406 - Gut. 2003 Feb;52(2):237-42 22301383 - Gut. 2012 Jul;61(7):1007-15 19273135 - Front Biosci (Landmark Ed). 2009;14:1362-86 16696804 - Aliment Pharmacol Ther. 2006 Jun 1;23(11):1567-74 16819502 - Nat Clin Pract Gastroenterol Hepatol. 2006 Jul;3(7):390-407 20517305 - Am J Gastroenterol. 2010 Oct;105(10):2218-27 15569116 - Aliment Pharmacol Ther. 2004 Nov 15;20(10):1133-41 19023901 - Inflamm Bowel Dis. 2009 May;15(5):653-60 11781279 - Gastroenterology. 2002 Jan;122(1):44-54 16988018 - J Clin Microbiol. 2006 Nov;44(11):3980-8 16648155 - Gut. 2006 Dec;55(12):1760-7 15574920 - Appl Environ Microbiol. 2004 Dec;70(12):7220-8 19235917 - Inflamm Bowel Dis. 2009 Jul;15(7):1022-31 17956582 - Clin Exp Immunol. 2007 Dec;150(3):531-8 19390523 - Obesity (Silver Spring). 2009 Oct;17(10):1906-15 22155109 - Am J Pathol. 2012 Feb;180(2):626-35 23044767 - Am J Gastroenterol. 2012 Dec;107(12):1913-22 12406736 - Appl Environ Microbiol. 2002 Nov;68(11):5445-51 |
| References_xml | – reference: 15867587 - Inflamm Bowel Dis. 2005 May;11(5):473-80 – reference: 22155109 - Am J Pathol. 2012 Feb;180(2):626-35 – reference: 22520466 - Cell Host Microbe. 2012 Apr 19;11(4):387-96 – reference: 18590586 - Br J Nutr. 2009 Feb;101(4):541-50 – reference: 17699621 - Proc Natl Acad Sci U S A. 2007 Aug 21;104(34):13780-5 – reference: 19714743 - Inflamm Bowel Dis. 2010 Mar;16(3):390-400 – reference: 12089021 - Appl Environ Microbiol. 2002 Jul;68(7):3401-7 – reference: 19273135 - Front Biosci (Landmark Ed). 2009;14:1362-86 – reference: 12406736 - Appl Environ Microbiol. 2002 Nov;68(11):5445-51 – reference: 17890331 - Appl Environ Microbiol. 2007 Nov;73(22):7435-42 – reference: 19390523 - Obesity (Silver Spring). 2009 Oct;17(10):1906-15 – reference: 17119388 - Inflamm Bowel Dis. 2006 Dec;12(12):1136-45 – reference: 15479682 - Gut. 2004 Nov;53(11):1617-23 – reference: 22301383 - Gut. 2012 Jul;61(7):1007-15 – reference: 16648155 - Gut. 2006 Dec;55(12):1760-7 – reference: 20816835 - Gastroenterology. 2010 Dec;139(6):1844-1854.e1 – reference: 15574920 - Appl Environ Microbiol. 2004 Dec;70(12):7220-8 – reference: 19174792 - Am J Gastroenterol. 2009 Feb;104(2):437-43 – reference: 19197385 - PLoS One. 2009;4(2):e4365 – reference: 14517348 - Mol Cancer Res. 2003 Sep;1(11):855-62 – reference: 17956582 - Clin Exp Immunol. 2007 Dec;150(3):531-8 – reference: 16696804 - Aliment Pharmacol Ther. 2006 Jun 1;23(11):1567-74 – reference: 11375166 - Appl Environ Microbiol. 2001 Jun;67(6):2578-85 – reference: 22132181 - PLoS One. 2011;6(11):e27961 – reference: 18936492 - Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16731-6 – reference: 16988018 - J Clin Microbiol. 2006 Nov;44(11):3980-8 – reference: 19023901 - Inflamm Bowel Dis. 2009 May;15(5):653-60 – reference: 3569765 - Gastroenterology. 1987 Jun;92(6):1894-8 – reference: 18242222 - Gastroenterology. 2008 Feb;134(2):577-94 – reference: 21219646 - BMC Microbiol. 2011;11:7 – reference: 15867588 - Inflamm Bowel Dis. 2005 May;11(5):481-7 – reference: 12374228 - Scand J Gastroenterol. 2002 Sep;37(9):1034-41 – reference: 23044767 - Am J Gastroenterol. 2012 Dec;107(12):1913-22 – reference: 21282652 - Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4623-30 – reference: 16819502 - Nat Clin Pract Gastroenterol Hepatol. 2006 Jul;3(7):390-407 – reference: 11781279 - Gastroenterology. 2002 Jan;122(1):44-54 – reference: 16000463 - J Clin Microbiol. 2005 Jul;43(7):3380-9 – reference: 19235917 - Inflamm Bowel Dis. 2009 Jul;15(7):1022-31 – reference: 15569116 - Aliment Pharmacol Ther. 2004 Nov 15;20(10):1133-41 – reference: 21530738 - Gastroenterology. 2011 May;140(6):1720-28 – reference: 20517305 - Am J Gastroenterol. 2010 Oct;105(10):2218-27 – reference: 22693446 - PLoS Pathog. 2012;8(5):e1002714 – reference: 19756155 - PLoS One. 2009;4(9):e7056 – reference: 19343057 - Nat Rev Immunol. 2009 May;9(5):313-23 – reference: 19026645 - Gastroenterology. 2009 Jan;136(1):65-80 – reference: 12524406 - Gut. 2003 Feb;52(2):237-42 – reference: 1248701 - Gastroenterology. 1976 Mar;70(3):439-44 |
| SSID | ssj0014455 |
| Score | 2.59633 |
| Snippet | Dysbiosis in the intestinal microbiota of persons with inflammatory bowel disease (IBD) has been described, but there are still varied reports on changes in... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 398 |
| SubjectTerms | Adolescent Adult Bacterial Load Bifidobacterium - isolation & purification Biopsy Biota Butyrates - metabolism Dysbiosis - microbiology Feces - microbiology Female Gastrointestinal Tract - microbiology Humans Inflammatory Bowel Diseases - microbiology Intestinal Mucosa - microbiology Lactobacillus - isolation & purification Male Middle Aged Real-Time Polymerase Chain Reaction RNA, Bacterial - genetics RNA, Ribosomal, 16S - genetics Young Adult |
| Title | Increased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/24478468 https://www.proquest.com/docview/1493794899 |
| Volume | 52 |
| WOSCitedRecordID | wos000330444200005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwFA7qVHzxMm_zRgRf49omzdonUXGIbGMPKnsbSZtAoWvnLsr-gr_akzRjT4IglD60pJT0O-d8yTk9H0I3XIbC1xElCYQPwgDCJJZaEB4yRUMI-cLKt713Wr1eNBjEfbfhNnVllUufaB11WiZmj7wJTJ4CdmB5cDf-IEY1ymRXnYTGOqpRoDKmpKs1WGURGLOqp77pmcm5N1gWvgdR8-Wxe2sW-x4xwga_kUsbZNp7_329fbTr6CW-r_BwgNZUUUdbleDkoo62uy6Vfoi-wTOYgnSV4rFRSphYAOJS44dMZymYuW3jPB9hUaQYaCLuGGkeuJzl-XyK7e8g9l4OcdaMk_PZwjSeIGPbRRZiInYPETgr4NCAvpHN6mNZfqkcu-zQEXprP70-PhMnzEAS4HMzooyCugZzVkLxUGkBbk9w7cvA45opEVPqyxjWYjT1fBEEIgrBjcZRCq435pIGx2ijKAt1inAkhRTAkRijCUsEl0GiDctMFOVUsLiBrpfzPQTgm2yGKFQ5nw5XM95AJ9VHG46rDh1D4CwtIFbR2R9Gn6MdIEGsqsS-QDUNZq8u0WbyOcumkyuLKDj3-t0fcqzYUQ |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Increased+proportions+of+Bifidobacterium+and+the+Lactobacillus+group+and+loss+of+butyrate-producing+bacteria+in+inflammatory+bowel+disease&rft.jtitle=Journal+of+clinical+microbiology&rft.au=Wang%2C+Wei&rft.au=Chen%2C+Liping&rft.au=Zhou%2C+Rui&rft.au=Wang%2C+Xiaobing&rft.date=2014-02-01&rft.issn=1098-660X&rft.eissn=1098-660X&rft.volume=52&rft.issue=2&rft.spage=398&rft_id=info:doi/10.1128%2FJCM.01500-13&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1098-660X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1098-660X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1098-660X&client=summon |